Trung Nguyen Thanh

Trung Nguyen Thanh

Auto-generated profile, based on publicly available information

Trung Nguyen Thanh

Hallym Neurological Institute, Hallym University, Anyang, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2025 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
JYJe Kook Yu
Je Kook Yu
HCHye Joung Choi
Hye Joung Choi
DKDongwoo Kim
Dongwoo Kim
PNPham Hong Ngoc
Pham Hong Ngoc
IKIn Hee Kwak
In Hee Kwak
YKYoung Eun Kim
Young Eun Kim

31 January 2026 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
JLJeongjae Lee
Jeongjae Lee
HKHan Joon Kim
Han Joon Kim
HNHuu Dat Nguyen
Huu Dat Nguyen
SSSuk Jun Song
Suk Jun Song
TTTrung Nguyen Thanh
Trung Nguyen Thanh
YKYoung Eun Kim
Young Eun Kim
Objective The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome has been proposed to be a downstream mediator of neuroinflammation in individuals with Parkinson’s disease (PD). However, its involvement across disease stages and related synucleinopathies, such as multiple system atrophy (MSA), remains unclear. We aimed to analyze the peripheral mRNA expression of NLRP3-related genes and cytokines across individuals with isolated REM sleep behavior disorder (iRBD), early-stage PD, late-stage PD, and MSA.Methods Peripheral blood mononuclear cells (PBMCs) were collected from 151 participants: 35 healthy controls (HCs), 31 patients with iRBD, 41 patients with early-stage PD, 21 patients with late-stage PD, and 23 patients with MSA. mRNA expression was measured using quantitative real-time polymerase chain reaction. Statistical comparisons were performed using analysis of variance (ANOVA) or Welch’s ANOVA, and associations with clinical variables were analyzed through stepwise multiple linear regression.Results NLRP3 expression was significantly lower in patients with iRBD (p=0.0263) and patients with early-stage PD (p= 0.0101) than in HCs. NIMA-related kinase 7 (NEK7) expression progressively decreased across the disease spectrum (HCs vs. patients with early-stage PD, p=0.0008; vs. patients with late-stage PD, p<0.0001). In contrast, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and caspase-1 were elevated in patients with PD, especially those in the late stages. Levels of patients with MSA resembled those of HCs but differed from those of patients with PD. Interleukin (IL)-1β and IL-18 levels were not significantly different. In patients with early-stage PD, NLRP3 expression was negatively correlated with disease duration, the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale Part II score, and the cognitive score.Conclusion Our findings challenge the prevailing hypothesis that NLRP3 inflammasome activation directly contributes to PD pathogenesis. Instead, the observed increase in ASC and caspase-1 expression suggests the potential involvement of alternative inflammasome pathways during disease progression.

21 September 2026 in Movement Disorders
Verified
Journal Article
Closed access
HTHoang Bao Tram Tran
Hoang Bao Tram Tran
HNHuu Dat Nguyen
Huu Dat Nguyen
TNThanh Trung Nguyen
Thanh Trung Nguyen
HCHye Joung Choi
Hye Joung Choi
SSSuk‐Jun Song
Suk‐Jun Song
YKYoung Eun Kim
Young Eun Kim

11 August 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
HCHYE JOUNG CHOI
HYE JOUNG CHOI
SSSuk Jun Song
Suk Jun Song
HNHuu Dat Nguyen
Huu Dat Nguyen
TNThanh Trung Nguyen
Thanh Trung Nguyen
HTHoang Bao Tram Tran
Hoang Bao Tram Tran
YKYoung Eun Kim
Young Eun Kim